Why should you join our platform?
You will have access to everything in our media library. This includes short and longer videos, articles, PDFs, tools, webinars, events, and more. If you choose, you will be notified when there are new launches on the platform and where to sign up to participate in diabetes-related research.
Registering for the platform is quick, easy, and completely free. Once you're signed up, you'll have access to a wealth of comprehensive, evidence-based, and reliable information designed to support your journey in managing diabetes. Our resources are tailored to meet diverse needs, offering up-to-date content that you can trust, all in one convenient place.
Explore the Knowing Diabetes Study Finder
The Knowing Diabetes Study Finder is a user-friendly AI tool designed for people with diabetes, their family members, and caregivers. By answering a few questions, you can quickly find nearby diabetes research studies seeking participants. Researchers and program facilitators can also submit their studies, keeping the database current and ensuring participants have access to the latest opportunities in diabetes research.
Read the latest articles
Discover our blog archive
What is An Evidence-Based Take?
When exploring the resources in the media library, you may notice videos that are called evidence-based takes (or EBTs). These cover a wide variety of topics including pregnancy and type 1 diabetes, type 2 diabetes remission, vaccinations and diabetes, diabetes and immunity, among others. An EBT is a short snippet from a conversation with a...
Learn more
Making Sense of Your Diabetes Lab Tests
After a routine appointment, your health care provider doctor hands you a requisition for a full panel of diabetes lab tests. These include HbA1c, creatinine, eGFR, LDL cholesterol, ALT, and a urine albumin-to-creatinine ratio. What does it all mean? While each test checks for something different, they are all designed to answer important questions about...
Learn more
What to Expect When Starting Semaglutide or Tirzepatide?
Semaglutide and tirzepatide are 2 drugs that are frequently used to manage type 2 diabetes. Semaglutide is marketed as either Ozempic or Wegovy and tirzepatide is marketed as either Mounjaro or Zepbound. They are excellent glucose lowering drugs and may also lower blood pressure. They also typically lower weight, reduce appetite and food cravings, with...
Learn more